Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.
Yiyao Di, Fan Yang, Conglu Che, Shenghui Xu, Ying Qi
{"title":"Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.","authors":"Yiyao Di, Fan Yang, Conglu Che, Shenghui Xu, Ying Qi","doi":"10.2147/IJGM.S522251","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The coexistence of chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) complicates diagnosis and treatment, increasing disease burden and mortality. The correlation between serum inflammatory factors and disease severity and prognosis in COPD patients with TB remains unclear.</p><p><strong>Methods: </strong>This retrospective study included 200 participants treated at the Affiliated Hospital of Hebei University from December 2020 to December 2022: 80 patients with COPD and TB, 40 with COPD alone, 40 with TB alone, and 40 healthy controls. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interferon-γ (IFN-γ), soluble IL-2 receptor (sIL-2R), and C-reactive protein (CRP) were compared across groups and correlated with disease severity and prognosis in COPD patients with TB.</p><p><strong>Results: </strong>Serum levels of TNF-α, IL-6, IFN-γ, sIL-2R, and CRP were significantly higher in the COPD with TB group compared to all other groups (P<0.05). In this group, elevated levels of these markers were associated with increased disease severity and poorer prognosis (P<0.05). Correlation analysis showed positive associations between inflammatory cytokine levels and disease severity, and negative associations with prognosis (P<0.05).</p><p><strong>Conclusion: </strong>Serum inflammatory markers may help assess disease severity and prognosis in COPD patients with TB. However, due to the observational design, causality cannot be inferred. Further prospective, multi-center studies are required to validate these findings before clinical application.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"18 ","pages":"3547-3556"},"PeriodicalIF":2.1000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12219164/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of General Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJGM.S522251","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The coexistence of chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) complicates diagnosis and treatment, increasing disease burden and mortality. The correlation between serum inflammatory factors and disease severity and prognosis in COPD patients with TB remains unclear.
Methods: This retrospective study included 200 participants treated at the Affiliated Hospital of Hebei University from December 2020 to December 2022: 80 patients with COPD and TB, 40 with COPD alone, 40 with TB alone, and 40 healthy controls. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interferon-γ (IFN-γ), soluble IL-2 receptor (sIL-2R), and C-reactive protein (CRP) were compared across groups and correlated with disease severity and prognosis in COPD patients with TB.
Results: Serum levels of TNF-α, IL-6, IFN-γ, sIL-2R, and CRP were significantly higher in the COPD with TB group compared to all other groups (P<0.05). In this group, elevated levels of these markers were associated with increased disease severity and poorer prognosis (P<0.05). Correlation analysis showed positive associations between inflammatory cytokine levels and disease severity, and negative associations with prognosis (P<0.05).
Conclusion: Serum inflammatory markers may help assess disease severity and prognosis in COPD patients with TB. However, due to the observational design, causality cannot be inferred. Further prospective, multi-center studies are required to validate these findings before clinical application.
期刊介绍:
The International Journal of General Medicine is an international, peer-reviewed, open access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas.
A key focus of the journal is the elucidation of disease processes and management protocols resulting in improved outcomes for the patient. Patient perspectives such as satisfaction, quality of life, health literacy and communication and their role in developing new healthcare programs and optimizing clinical outcomes are major areas of interest for the journal.
As of 1st April 2019, the International Journal of General Medicine will no longer consider meta-analyses for publication.